Stents having radiopaque mesh

Abstract
A stent including a mesh made of strands. The mesh has at least one radiopaque strand and at least one non-radiopaque strand, and the at least one radiopaque strand and the at least one non-radiopaque strand each have different diameters. Each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I). The EI of all strands in the mesh is no more than five times the EI of the strand having the smallest EI of any of the strands.
Description
FIELD OF THE INVENTION

The present invention relates to embolic protection systems, and, more particularly, to embolic protection systems for use in blood vessels.


BACKGROUND OF THE INVENTION

Vessels are commonly treated to reduce or eliminate narrowings caused by arteriosclerotic disease. Interventional treatments can include use of balloon angioplasty, stenting, thrombectomy, atherectomy, and other procedures. During treatment particulate debris can be generated at the treatment site. Infarcts, strokes, and other major or minor adverse events are caused when debris embolizes into vasculature distal to the treatment site.


To prevent embolization of debris, embolic protection devices have been developed. During a procedure such devices can be placed distal or proximal to the treatment site. Embolic protection devices can remove emboli from the bloodstream by filtering debris from blood, by occluding blood flow followed by aspiration of debris, or can cause blood flow reversal to effect removal of debris. The shape, length and other characteristics of an embolic protection device are typically chosen based on the anatomical characteristics in the vicinity of the treatment site. However, some anatomies present specific challenges due to the anatomical shape or configuration.


Difficulties can arise where embolic protection devices are not properly deployed within the anatomy. For example, if a device does not properly engage a lumenal wall, leaving a gap, then particulate matter entrained in a fluid in the lumen can bypass the protection device. It would be an advantage to be able to visualize whether or not there are gaps between the embolic protection device and the lumenal wall. Also, when a protection device is being advanced or withdrawn from a lumen it may engage with an obstruction. The obstruction may be a stent that has been placed in a blood vessel, an area of plaque build-up, lumen tortuosity, or other structure. The operator of the embolic protection device may need to employ different techniques to advance or withdraw the device depending on the cause of engagement. Thus, it would be advantageous for the operator to be able to visualize the exact location of the device in the lumen.


Difficulties can also arise when recovering an embolic protection device. One problem that can occur is that the embolic protection device may require excessive force during recovery, for example when drawing the device into a recovery catheter. The causes of such excessive force can vary. For example the device could be filled with embolic debris and thereby not fit into the lumen of a recovery catheter, the device may be caught on a structure such as a stent or a catheter tip, or other causes. It would be advantageous to the operator to visualize the embolic protection device so that appropriate actions can be taken so as to successfully recover the device. Further discussion of these issues is provided in U.S. Patent Publication No. 2002/0188314 A1, by Anderson et. al., entitled “Radiopaque Distal Embolic Protection Device”, the contents of which are incorporated herein by reference.


The current art employs a variety of approaches to solve the problem of visualizing an embolic protection device in a patient. All of the current approaches have limitations. For example, some devices have radiopaque coatings; however coatings may become separated from the underlying substrate. Radiopaque filler materials have been employed in polymer film devices; however the fillers detract from the mechanical properties of the films and the filler/film composites, being thin, are not very visible. Strands of drawn filled tubing (DFT) have been used and have good mechanical and radiopacity characteristics; however DFT is expensive. Individual strands of radiopaque wire, such as platinum, gold, tungsten, and their alloys have good radiopacity but can have unsuitable strength or elastic yield limits, and when comprising a portion of the wires in a woven structure such as a braid, can alter the braid wire spacing in the vicinity of the strand of radiopaque wire due to differing mechanical properties compared to neighboring non-radiopaque wires. For some filter devices, uniform wire spacing is desired and altered braid wire spacing can cause unacceptably large pores in the braid.


Accordingly, a need exists for an embolic protection device having improved radiopacity that is inexpensive, durable, provides visibility to the appropriate regions of the device, and which uses technology that does not compromise the performance of the device.


SUMMARY OF THE INVENTION

According to one aspect of the present invention, an embolic protection device comprises a woven mesh comprising radiopaque and non-radiopaque wires. The mechanical properties of the radiopaque wires are selected to match the mechanical properties of the non-radiopaque wires. The non-radiopaque wires can be superelastic. The radiopaque wires are woven into pre-programmed locations so that after processing the woven mesh into a device the radiopaque wires will concentrate at a preferred location within the device. A method is provided in which the device operator visualizes the radiopaque wires so as to guide how the device is utilized in a patient.


The invention provides a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body, comprising: a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand.


The invention provides a method of deploying a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body comprising: providing the device for filtering emboli, the device comprising a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand; delivering the device percutaneously to a region of interest in the lumen of the patient's body; and using fluoroscopy to visualize the filter element in the lumen of the patient's body.


The invention provides a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand.


It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.





BRIEF DESCRIPTION OF THE DRAWINGS

The above and further advantages of the invention may be better understood by referring to the following description in conjunction with the accompanying drawings.



FIGS. 1A to 1C illustrate conceptually a partial plan view of braided tubular mesh having radiopaque and non-radiopaque wires in accordance with the present invention.



FIG. 2 illustrates conceptually a side view of a filter formed from braided tubular mesh in accordance with the present invention.



FIG. 3 illustrates conceptually a method for forming a filter from braided tubular mesh in accordance with the present invention.



FIGS. 4A and 4B illustrate conceptually plan views of braided mesh in accordance with the present invention.



FIGS. 5A to 5E illustrate cross sectional or side views of wires in accordance with the present invention.





DETAILED DESCRIPTION OF THE INVENTION

The invention provides a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body, comprising: a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand.


In one embodiment, the device further comprises an elongate support member and the filter element is carried on a portion of the elongate support member. In another embodiment, the filter element has proximal and distal portions and a central portion, the filter element having a shape in the expanded configuration which defines a cavity having a proximal facing opening. In one embodiment, the filter element has a proximal facing opening portion and this portion is radiopaque.


The filter element may be self-expanding or self-contracting. The mesh may be tubular and/or braided. In one embodiment, each strand has a round cross-section. In another embodiment, the mesh comprises only two types of strands, a first type being a radiopaque strand and having a diameter D1 and a second type being a non-radiopaque strand and having a diameter D2. In one embodiment, the Young's modulus of the radiopaque strand and the Young's modulus of the non-radiopaque strand differ by 10 percent or more. In another embodiment, the Young's modulus of the radiopaque strand and the Young's modulus of the non-radiopaque strand differ by 20 percent or more.


In one embodiment, the mesh comprises more radiopaque strands than non-radiopaque strands. In another embodiment, the mesh comprises more non-radiopaque strands than radiopaque strands. In embodiments of the invention, the largest EI of a strand is no more than four times the smallest EI of a strand, the largest EI of a strand is no more than two times the smallest EI of a strand, the largest EI of a strand is no more than 1.5 times the smallest EI of a strand, or the largest EI of a strand is no more than 1.3 times the smallest EI of a strand.


In embodiments of the invention, the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than five times the mesh pore size, when the mesh is at rest in free space no pore has an area more than four times the mesh pore size, when the mesh is at rest in free space no pore has an area more than three times the mesh pore size, when the mesh is at rest in free space no pore has an area more than two times the mesh pore size, when the mesh is at rest in free space no pore has an area more than 1.5 times the mesh pore size, or when the mesh is at rest in free space no pore has an area more than 1.2 times the mesh pore size. The mesh pore size is the average area of five pores serially adjacent to the pore.


In embodiments of the invention, the mesh comprises at least two types of strands, each strand having a round cross-section, a first type of strand being a radiopaque strand and having a diameter D1 and a second type of strand being a non-radiopaque strand and having a diameter D2, diameter D1 being larger than diameter D2, wherein the mesh comprises pores and when the mesh is at rest in free space no pore adjacent to a strand having a diameter D1 has an area more than five times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore. In other related embodiments, when the mesh is at rest in free space no pore adjacent to a strand having a diameter D1 has an area more than four times the mesh pore size, more than three times the mesh pore size, more than two times the mesh pore size, more than 1.5 times the mesh pore size, or more than 1.2 times the mesh pore size.


In one embodiment, the at least one radiopaque strand is made of homogeneous metal or metal alloy. In another embodiment, the at least one radiopaque strand is selected from the group consisting of strands made of gold, platinum, tungsten, tantalum, and alloys thereof. Other radiopaque substances may be used. In an embodiment, the at least one non-radiopaque strand is made of metal. In one embodiment, the at least one non-radiopaque strand is selected from the group consisting of strands made of stainless steel and nitinol. Other non-radiopaque substances may be used. In one embodiment, the at least one non-radiopaque strand is superelastic.


In embodiments of the invention, the largest diameter of a strand is no more than five times the smallest diameter of a strand, the largest diameter of a strand is no more than four times the smallest diameter of a strand, the largest diameter of a strand is no more than two times the smallest diameter of a strand, or the largest diameter of a strand is no more than 1.5 times the smallest diameter of a strand. In one embodiment, the largest diameter of a strand is no more than two times the smallest diameter of a strand, and the largest EI of a strand is no more than two times the smallest EI of a strand.


In one embodiment, the at least one radiopaque strand is a monofilament. In one embodiment, the at least one non-radiopaque strand is a monofilament. In another embodiment, the mesh comprises only two types of strands, a first type being a radiopaque strand and having a diameter D1 and a second type being a non-radiopaque strand and having a diameter D2, and both the first and second types of strands are monofilaments. In one embodiment, the at least one radiopaque strand is a multifilament wire. In another embodiment, at least one strand is a monofilament wire from which some material has been removed in the form of slots. In one embodiment, the at least one non-radiopaque strand is made of nitinol.


The invention provides a method of deploying a device for filtering emboli from blood flowing through a lumen defined by the walls of a vessel in a patient's body comprising: providing the device for filtering emboli, the device comprising a filter element being expandable from a collapsed configuration when the filter element is restrained to an expanded configuration when the filter element is unrestrained, wherein the filter element comprises a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand; delivering the device percutaneously to a region of interest in the lumen of the patient's body; and using fluoroscopy to visualize the filter element in the lumen of the patient's body. The device used in this method can be any of the embodiments described herein. In one embodiment, the filter element has proximal and distal portions and a central portion, the filter element having a shape in the expanded configuration which defines a cavity having a proximal facing opening, the filter element has a proximal facing opening portion and this portion is radiopaque, and the proximal facing opening portion of the filter element is visualized to confirm that this portion is adequately deployed against the walls of the vessel.


The invention provides a mesh comprising strands, each strand having a diameter, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, and wherein each strand has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the largest EI of a strand is no more than five times the smallest EI of a strand. The mesh can be any of the embodiments described herein in connection with the mesh that is part of the device for filtering emboli.


In the discussion below the invention is described using as examples filters comprised of braided metal strands. It is to be understood that the invention is not limited to the examples below. For example, the mesh of the invention can be comprised of strands that are woven, non-woven, or knitted to form the mesh. The mesh can have uniform strand spacing so as to define a structure with relatively uniformly sized openings between strands or can have variable strand spacing so as to define a structure with varied size openings between strands. The mesh can be coated with an elastic polymer film in whole or in part, or with another material, so as to reduce in size or eliminate the openings between strands. The coated mesh may be partially or totally occlusive to flow of fluid or particles therethrough. In some embodiments the metal strands may be superelastic alloys comprised of radiopaque alloy constituents. In some preferred embodiments a metal strand is comprised of nickel-titanium-platinum or nickel-titanium-tantalum alloy. In addition, some or all of the strands may be comprised of materials other than metal including but not limited to engineering polymers such as PEEK (polyetheretherketone), liquid crystal, polyamide, or polyester; ceramics; glass-ceramics; metallic glasses; or other materials known in the art. In some embodiments the aforementioned materials can be comprised of radiopaque filler materials. In some embodiments the strands are homogeneous in the sense that they are not comprised of separate layers. It is further understood that the cross section of some or all of the strands can be round, ovoid, square, rectangular, triangular, irregular, symmetrical, non-symmetrical, or other shapes.



FIGS. 1A to 1C illustrate conceptually partial plan views of braided meshes having radiopaque and non-radiopaque wires in accordance with the present invention. For clarity only the braided wires along half of the braided perimeter of the tube are shown. Braided wires arranged below the illustrated wires are not shown. Also for clarity the radiopaque wires in FIGS. IA to IC are shown as having slightly increased diameter as compared to non-radiopaque wires, although it is understood that the relative sizes of the radiopaque and non-radiopaque filaments may not be as illustrated and generally will be determined according to the teachings below. Further, strands are generally illustrated as intersecting at angles of approximately 900, although it is understood that within the scope of the invention strands can intersect or overlap at any angle.


In FIG. IA braided tubular mesh 10 is comprised of interwoven wires 12 and 14. Non-radiopaque wires 12 comprise the majority of the wires and two sets of adjacent pairs of radiopaque wires 14 are interwoven with the non-radiopaque wires 12. Braided tubular mesh 10 has a number of pores 16 defined by the wires, and each pore has a size, the pore size defined as the area bounded by the wires forming the perimeter of the pore. Braided tubular mesh 10 can be formed of a variety of materials. Metal wires are preferred, and superelastic nitinol is particularly preferred for the non-radiopaque wires 12. Braided tubular mesh 10 has a diameter D, which is the diameter of the braided tubular mesh at rest in free space. Diameter D is determined by braiding processing parameters and wire diameters used. Heat treatments may be used to help stabilize diameter D, especially when wire materials such as nitinol are used. A braid comprised of nitinol wire is typically heat set at 400 to 600° C. for 1 to 60 minutes to stabilize the braid diameter. In a preferred embodiment nitinol wire is heat set at 425° C. for 20 minutes to stabilize the braid diameter. Non-nitinol wires may be annealed at temperatures that will stress relieve or even recrystallize the materials in order to stabilize the tubular braid diameter. It is understood that self-expanding or self-contracting devices can be comprised of braided tubular mesh 10. Self-expanding devices are devices in which, during use, braided tubular mesh 10 is compressed and subsequently allowed to expand without application of forces external to the mesh for causing expansion. Self-contracting devices are devices in which, during use, braided tubular mesh 10 is expanded and subsequently allowed to contract without application of forces external to the mesh for causing contraction. It is advantageous to construct self-expanding or self-contracting devices at least in part from wires that have elastic strain limits higher than the elastic strains generated in the wires during use of these devices, and to process the wires so as to retain or enhance the elastic strain limits of the wires chosen. Devices which are neither self-expanding nor self-contracting may also be comprised of braided tubular mesh 10. Devices of the invention may also be comprised of braided tubular mesh or strands which deform upon expansion or contraction. The strands of such devices may be processed or chosen such that the elastic strain limit of the strands are less than the elastic strains generated in the strand during use of the device.



FIG. 1B illustrates braided tubular mesh 10 comprised of a single radiopaque wire 14 interwoven with non-radiopaque wires 12 and FIG. 1C illustrates braided tubular mesh 10 comprised primarily of radiopaque wires 14 interwoven with a minority of non-radiopaque wires 12. It is understood that multiple combinations of interwoven radiopaque and non-radiopaque wires 14 and 12 are possible within the scope of the invention, and that the number, proportion, and positioning of radiopaque and non-radiopaque wires within the mesh will be chosen based on the desired device functional and other requirements.



FIG. 2 illustrates conceptually a side view of filter 20 formed from a braided tubular mesh 10 comprised of interwoven radiopaque and non-radiopaque wires 12 and 14 in accordance with the present invention. For clarity the wires on the back side of the filter are not shown. Filters similar to that shown in FIG. 2 can be made by enlarging a pore in the side wall of the braid using a tapered mandrel and stabilized in the desired shape by heat treating on a mandrel. Processing details for making a filter using these methods are disclosed in U.S. Pat. No. 6,325,815 B1 to Kusleika et al., entitled “Temporary Vascular Filter”, the contents of which are incorporated herein by reference. In filter 20, radiopaque wires 14 are bunched at the opening of the filter, providing improved visibility under fluoroscopy of the perimeter 26 of mouth 24 of the filter. In an alternate embodiment radiopaque wires 14 are bunched distal to mouth 24 of the filter, providing improved visibility under fluoroscopy of the portion of the filter apposing a vessel wall during use. Radiopaque wires 14 also extend throughout the body 22 of the filter mesh, providing visibility under fluoroscopy to the body of the filter.



FIG. 3 illustrates conceptually a method for forming filter 20 from braided tubular mesh 10 comprised of interwoven radiopaque and non-radiopaque wires 12 and 14 in accordance with the present invention. Pore 35 is chosen as the pore to enlarge into mouth 24 of filter 20. Pore 35 is chosen specifically such that radiopaque wires 14a will be bunched along the perimeter 26 of filter mouth 24 during the filter forming process. In FIG. 3, pore 35 is located 3 pores from the intersecting pore 38 of radiopaque filaments 14a. In one example, braided tubular mesh 10 is comprised of 36 wires and has a diameter D of 3 mm before forming into filter 20. Two pairs of radiopaque wires 14a are interwoven into tubular mesh 10 as illustrated in FIG. 3, and the remaining 32 wires are non-radiopaque nitinol. Pore 35 is located 8 pores from intersecting pore 38 of radiopaque filaments 14a. In another example, braided tubular mesh 10 is comprised of 72 wires and has a diameter D of 7 mm before forming into filter 20. Two pairs of radiopaque wires 14a are interwoven into tubular mesh 10 as illustrated in FIG. 3, and the remaining 68 wires are non-radiopaque. Pore 35 is located 15 pores from intersecting pore 38 of radiopaque filaments 14a. It is understood that the location chosen for piercing braided tubular mesh 10 comprised of interwoven radiopaque and non-radiopaque wires 12 and 14 will vary within the scope of the invention and will depend on the application contemplated and results desired.


When adding radiopaque wires to a mesh comprised primarily of non-radiopaque wires it is often desired to increase the diameter of the radiopaque wire relative to the diameter of the non-radiopaque wire so as to increase the visibility of the radiopaque wire under fluoroscopy. FIG. 4A illustrates the effect of adding a larger wire 42 to a mesh 40, wherein the pore sizes 45 adjacent to the larger wires are increased in area as compared to pore sizes 47 in the portion of the mesh comprised of smaller wires 44 due to the presence of the larger wire 42 relative to the adjacent smaller wires 44 in the mesh. For certain applications, including some filter devices, large pores in the braid can be unacceptable because the large pores will allow large emboli to pass through the filter.



FIG. 4B illustrates braided tubular mesh 40 comprised of a large wire 42 and multiple smaller wires 44 having uniformly sized pores 48, a configuration preferred for filtering applications such as for distal embolic protection devices. The uniformly sized pores illustrated in FIG. 4B are achieved by using similar stiffness wires in the mesh. A useful index of wire stiffness is EI, where E is the Young's modulus of the wire material, I is the second moment of area of the wire, and EI is the mathematical product of the two. In a preferred embodiment of the device, the largest EI of wires used in the device is no more than 5 times the smallest EI of wires used in the device. In a more preferred embodiment of the device, the largest EI of wires used in the device is no more than 4 times the smallest EI of wires used in the device. In a further preferred embodiment of the device, the largest EI of wires used in the device is no more than 2 times the smallest EI of wires used in the device. In a further preferred embodiment of the device, the largest EI of wires used in the device is no more than 1.5 times the smallest EI of wires used in the device. In a further preferred embodiment of the device, the largest EI of wires used in the device is no more than 1.3 times the smallest EI of wires used in the device.


Referring again to FIG. 4A, the area of pore 45a adjacent to large wire 42 is much greater than the average area of the five pores 47a, 47b, 47c, 47d, and 47e serially adjacent to pore 45a. For convenience we hereby define the average area of the five pores 47a, 47b, 47c, 47d, and 47e serially adjacent to pore 45a as the mesh pore size. This definition allows us to apply the inventive teachings herein to various filter shapes with varying pore sizes, including tapered filters where the pore size varies along the length of the filter, such as the filter illustrated in FIG. 2. In a preferred embodiment of the mesh at rest in free space, the size of pore 45a adjacent to large wire 42 is no more than 5 times larger than the mesh pore size. In a more preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 4 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 3 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 2 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 1.5 times larger than the mesh pore size. In a further preferred embodiment of the mesh, the size of pore 45a adjacent to large wire 42 in the mesh at rest in free space is no more than 1.2 times larger than the mesh pore size.


To achieve the uniform pore size illustrated in FIG. 4B various approaches can be used to match wire stiffnesses. In one embodiment a tubular braided mesh of monofilament 52 (see FIG. 5A) stainless steel wires incorporates an interwoven monofilament wire having a larger diameter than the stainless steel wires with the Young's modulus of the interwoven larger wire less than that of stainless steel. Suitable choices of material for the larger wire include gold and platinum (see Table I below). The lower modulus of gold and platinum relative to stainless steel will offset the larger diameter of the radiopaque wire such that the calculated EI's of the radiopaque and non-radiopaque wires will be equal or similar.












TABLE 1







Material
Young's Modulus, E (GPa)









Gold
 78



Nitinol (Austenitic)
75-83



Platinum
168



Tungsten
411



Tantalum
186



Stainless Steel
199










In an alternate embodiment, multifilament wires 53 can be used (see FIG. 5B). The diameter of each individual filament 54 of a multifilament wire is smaller than the overall diameter of the wire 53 and this allows higher modulus materials to be incorporated into some or all of the filaments 54 of a larger multifilament wire 53. For example, braided tubular mesh comprised of nitinol monofilament wires could incorporate one or more interwoven multifilament wires comprised of gold, platinum, tungsten, tantalum, or other radiopaque materials. In one embodiment of a multifilament wire more than one filament is twisted into a helical shape around a central filament. In another embodiment of multifilament wire 53 individual monofilaments are interwoven into the braid adjacent to each other as shown in FIG. 5E. It is understood that many other combinations of filaments can be devised by one skilled in the art within the scope of the invention.


In a further embodiment, FIGS. 5C and 5D illustrate slotted wire 56 in which monofilament wire 57 has had material removed in the form of slots 58, for example by grinding. Slots 58 have opposing faces 59 and due to material having been removed from the perimeter of the wire to form slots 58 the overall modulus of wire 56 is reduced.


One example of deriving uniform pore size by matching wire stiffnesses is as follows. Tubular braided mesh is comprised of 36 Nitinol monofilament wires of 0.003″ (0.0076 cm) diameter. It is desired to improve the visibility of the mesh by substituting a monofilament circular cross section tungsten wire for one of the nitinol wires, and to do so without significantly changing the pore size of the mesh. The appropriate diameter of the tungsten wire is calculated as shown below.

1/ρ=M/(E×I)

    • Where ρ=the density of the material in bending, M=the bending moment, and E & I are as defined above. Equating the bending moments of nitinol and tungsten wires yields:

      (Ew×Iw)/ρw=M=(ENiTi×INiTi)/ρNiTi and I=(πd2L3ρ)/(48 g)
    • Where π=3.14159, d=monofilament diameter, L=the unsupported transverse length of the filament, and g=the gravitational constant
    • By combining terms:
      • Ew×(πdw2Lw3ρw)/(48 g ρw)=ENiTi×(1tdNiTi2LNiTi3ρNiTi)/(48 g ρNiTi) and by eliminating like terms:
      • Ew×dw−ENiTi×dNiTi2
    • Substituting known values and solving for dw yields
    • dw=0.0013″(0.0033 cm)


In another example, the appropriate diameter of gold wire to be substituted into the mesh, using the same calculation as above except substituting into the equations the material parameters of gold in place of the parameters of tungsten, would be dAu=0.0031″ (0.0079 cm).


In yet another example, the appropriate diameter of nitinol monofilament wires to be braided with 0.0024″ (0.0061 cm) outer diameter 1×7 stranded tungsten wire (constructed from a central monofilament of tungsten surrounded by a ring of 6 tungsten monofilaments of the same diameter as the central filament) into tubular braided mesh having uniform pore size is calculated as follows. The equations above are used to calculate EI for each individual tungsten filament (having a filament diameter of 0.0008″ (0.002 cm) in this example). The EI of the stranded wire is approximated as seven times that of one tungsten monofilament (assuming the friction between filaments is small compared to the bending stiffness of the filaments, therefore no adjustment is made for friction). The equations above are solved for dNiTi by equating EI for the nitinol wire with the calculated EI for the tungsten stranded wire. In this example dNiTi is approximately equal to 0.0047″ (0.012 cm). It is understood that improved calculations for the stiffness of multifilament wire can be employed as part of these calculations. Improved calculations may account for frictional forces between strands, non-linear configuration of some or all of the strands, or other factors.


Another means for achieving uniform pore size braided mesh comprised of some radiopaque wires is by matching radiopaque and non-radiopaque wire diameters. The smaller the distance between interwoven radiopaque and non-radiopaque wires the greater the variation in pore size caused by differing wire diameters. In a preferred embodiment of the device, the largest diameter of wires used in the device is no more than 5 times the smallest diameter of wires used in the device. In a more preferred embodiment of the device, the largest diameter of wires used in the device is no more than 4 times the smallest diameter of wires used in the device. In a further preferred embodiment of the device, the largest diameter of wires used in the device is no more than 2 times the smallest diameter of wires used in the device. In a further preferred embodiment of the device, the largest diameter of wires used in the device is no more than 1.5 times the smallest diameter of wires used in the device. In a most preferred embodiment both the wire diameter and the wire stiffness of both the radiopaque and non-radiopaque wires are similar.


A method of using a device made from the inventive mesh is as follows. An embolic protection device, made using methods similar to those discussed in connection with FIG. 2, is delivered percutaneously to a region of interest in the body of a patient using methods known in the art. Optionally a catheter is used to deliver the filter to the region of interest. Fluoroscopy is used by the operator to visualize the mouth and the body of the filter to ascertain that the filter is positioned appropriately in relation to a treatment or diagnostic site, for example, positioned such that the mouth of the filter is distal to a stenosis in an artery, and also by example, positioned such that the body of the filter is in a healthy region of vessel suitable for use as a landing zone for the filter. The filter is then deployed and the catheter (if used) is removed from the vicinity of the filter. The operator uses fluoroscopy to ascertain that the mouth of the filter is adequately deployed against the vessel wall with no gaps, distal to the lesion, and proximal to any important side branch vessels. Radiopaque contrast media may be injected at this time or at any time to assist with visualization of the patient's anatomy. The treatment site is treated, for example by dilating a lesion with a balloon dilatation catheter and by deploying a stent or drug eluting stent at the treatment site, although other methods known in the art can be used.


After or during treatment or both, the operator may visualize the mouth and body of the device and may adjust the position of the device to assure, for example, that the device is properly located along the length of the vessel and properly apposed to the vessel wall. After treatment the device is recovered. Optionally a catheter is used during the recovery process. At least a portion of the filter is drawn into the recovery catheter (if used) and the mouth and body of the filter are observed under fluoroscopy to ascertain when the device is sufficiently drawn into the catheter. If difficulty is encountered while drawing the filter into the catheter the devices are again imaged under fluoroscopy and the cause of the difficulty is diagnosed in part by observing the radiopaque portions of the device. The filter (and recovery catheter if used) are then withdrawn from the vessel. If resistance to withdrawal is encountered then the devices are imaged under fluoroscopy and the cause of resistance is determined and eliminated.


While this document has described an invention mainly in relation to braided tubular mesh used for embolic protection filtering devices used in arteries, it is envisioned that the invention can be applied to other conduits in the body as well including veins, bronchi, ducts, ureters, urethra, and other lumens intended for the passage of air, fluids, or solids. The invention can be applied to other devices such as vena cava filters, stents, septal defect closure devices, and other devices comprised of mesh having the benefits described above.


While the various embodiments of the present invention have related to embolic protection filtering devices, the scope of the present invention is not so limited. Further, while choices for materials and configurations have been described above with respect to certain embodiments, one of ordinary skill in the art will understand that the materials described and configurations are applicable across the embodiments.


The above description and the drawings are provided for the purpose of describing embodiments of the invention and are not intended to limit the scope of the invention in any way. It will be apparent to those skilled in the art that various modifications and variations can be made without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.

Claims
  • 1. A method, comprising: expanding, against a wall of a vessel in a body of a patient, a stent comprising a mesh, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, the at least one radiopaque strand and the at least one non-radiopaque strand each having different cross-sectional dimensions, and wherein each of the strands has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the EI of each non-radiopaque strand is no more than five times the EI of a strand having the smallest EI of any of the strands.
  • 2. The method of claim 1, wherein expanding the stent comprises positioning a mouth of the stent proximal to a side branch vessel.
  • 3. The method of claim 1, wherein each strand has a round cross-section.
  • 4. The method of claim 1, wherein the mesh comprises only two types of strands, a first type comprising the at least one radiopaque strand and having a cross-sectional dimension D1 and a second type comprising the at least one non-radiopaque strand and having a cross-sectional dimension D2, wherein the cross-sectional dimension D2 is greater than the cross-sectional dimension D1.
  • 5. The method of claim 1, wherein the EI of each of the strands is no more than four times the EI of a strand having the smallest EI of any of the strands.
  • 6. The method of claim 1, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than 1.2 times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.
  • 7. The method of claim 1, wherein the at least one radiopaque strand is an alloy of platinum and tungsten and the at least one non-radiopaque strand comprises nickel.
  • 8. A method comprising: expanding, against a wall of a vessel in a body of a patient, a stent comprising a mesh, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, the at least one radiopaque strand and the at least one non-radiopaque strand each having different cross-sectional dimensions, and wherein each of the strands has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the EI of each non-radiopaque strand is no more than five times the EI of each radiopaque strand.
  • 9. The method of claim 8, wherein each strand has a round cross-section.
  • 10. The method of claim 8, wherein the mesh comprises only two types of strands, a first type comprising the at least one radiopaque strand and having a cross-sectional dimension D1 and a second type comprising the at least one non-radiopaque strand and having a cross-sectional dimension D2, wherein the cross-sectional dimension D2 is greater than the cross-sectional dimension D1, and wherein the cross-sectional dimension D2 is no more than 1.5 times the cross-sectional dimension D1.
  • 11. The method of claim 8, wherein the Young's modulus of the radiopaque strand and the Young's modulus of the non-radiopaque strand differ by 20 percent or more.
  • 12. The method of claim 8, wherein the mesh comprises more non-radiopaque strands than radiopaque strands.
  • 13. The method of claim 8, wherein the EI of each of the strands is no more than four times the EI of a strand having the smallest EI of any of the strands.
  • 14. The method of claim 8, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than 1.2 times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.
  • 15. The method of claim 8, wherein the at least one radiopaque strand is an alloy of platinum and tungsten and the at least one non-radiopaque strand comprises nickel.
  • 16. A method comprising: expanding, against a wall of a vessel in a body of a patient, a stent comprising a mesh, the mesh comprising at least one radiopaque strand and at least one non-radiopaque strand, the at least one radiopaque strand and the at least one non-radiopaque strand each having different cross-sectional dimensions, and wherein each of the strands has an index of wire stiffness EI, where EI is the mathematical product of the Young's modulus (E) and the second moment of area (I), and wherein the EI of each radiopaque strand is no more than five times the EI of a strand having the smallest EI of any of the strands.
  • 17. The method of claim 16, wherein each strand has a round cross-section.
  • 18. The method of claim 16, wherein the mesh comprises only two types of strands, a first type comprising the at least one radiopaque strand and having a cross-sectional dimension D1 and a second type comprising the at least one non-radiopaque strand and having a cross-sectional dimension D2, wherein the cross-sectional dimension D2 is greater than the cross-sectional dimension D1.
  • 19. The method of claim 16, wherein the Young's modulus of the at least one radiopaque strand and the Young's modulus of the at least one non-radiopaque strand differ by 20 percent or more.
  • 20. The method of claim 16, wherein the EI of each of the at least one non-radiopaque strand is no more than four times the EI of any radiopaque strand.
  • 21. The method of claim 16, wherein the mesh comprises pores and when the mesh is at rest in free space no pore has an area more than 1.2 times the mesh pore size, the mesh pore size being the average area of five pores serially adjacent to the pore.
  • 22. The method of claim 16, wherein the at least one radiopaque strand is an alloy of platinum and tungsten and the at least one non-radiopaque strand comprises nickel.
Parent Case Info

This application is a continuation of U.S. application Ser. No. 13/792,344, filed Mar. 11, 2013, which is a continuation of U.S. application Ser. No. 13/407,044, filed Feb. 28, 2012, now U.S. Pat. No. 8,394,119, issued Mar. 12, 2013, which is a continuation of U.S. application Ser. No. 11/708,651, filed Feb. 20, 2007, now U.S. Pat. No. 8,152,833, issued Apr. 10, 2012, which claims the benefit of U.S. Provisional Application No. 60/775,818, filed Feb. 22, 2006, the contents of each of which are hereby incorporated by reference herein.

US Referenced Citations (647)
Number Name Date Kind
2919467 Mercer Jan 1960 A
4321711 Mano Mar 1982 A
4503569 Dotter Mar 1985 A
4512338 Balko et al. Apr 1985 A
4538622 Samson et al. Sep 1985 A
4572186 Gould et al. Feb 1986 A
4580568 Gianturco Apr 1986 A
4655771 Wallsten Apr 1987 A
4681110 Wiktor Jul 1987 A
4733665 Palmaz Mar 1988 A
4743251 Barra May 1988 A
4768507 Fischell et al. Sep 1988 A
4776337 Palmaz Oct 1988 A
4856516 Hillstead Aug 1989 A
4954126 Wallsten Sep 1990 A
5011488 Ginsburg Apr 1991 A
5035706 Giantureo et al. Jul 1991 A
5041126 Gianturco Aug 1991 A
5061275 Wallsten et al. Oct 1991 A
5108416 Ryan et al. Apr 1992 A
5160341 Brenneman et al. Nov 1992 A
5180368 Garrison Jan 1993 A
5192297 Hull Mar 1993 A
5197978 Hess Mar 1993 A
5201757 Heyn et al. Apr 1993 A
5209731 Sterman et al. May 1993 A
5242399 Lau et al. Sep 1993 A
5246420 Kraus et al. Sep 1993 A
5246445 Yachia et al. Sep 1993 A
5330500 Song Jul 1994 A
5344426 Lau et al. Sep 1994 A
5360443 Barone et al. Nov 1994 A
5382259 Phelps et al. Jan 1995 A
5401257 Chevalier, Jr. et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5405380 Gianotti et al. Apr 1995 A
5415637 Khosravi May 1995 A
5421826 Crocker et al. Jun 1995 A
5423849 Engelson et al. Jun 1995 A
5449372 Schmaltz et al. Sep 1995 A
5458615 Klemm et al. Oct 1995 A
5476505 Limon Dec 1995 A
5480423 Ravenscroft et al. Jan 1996 A
5484444 Braunschweiler Jan 1996 A
5489295 Piplani et al. Feb 1996 A
5507767 Maeda et al. Apr 1996 A
5507768 Lau et al. Apr 1996 A
5522822 Phelps et al. Jun 1996 A
5534007 St. Germain et al. Jul 1996 A
5545208 Wolff et al. Aug 1996 A
5546880 Ronyak et al. Aug 1996 A
5549662 Fordenbacher Aug 1996 A
5562641 Flomenblit et al. Oct 1996 A
5562728 Lazarus et al. Oct 1996 A
5591225 Okuda Jan 1997 A
5599291 Balbierz et al. Feb 1997 A
5601593 Freitag Feb 1997 A
5607466 Imbert et al. Mar 1997 A
5609625 Piplani et al. Mar 1997 A
5626602 Gianotti et al. May 1997 A
5628783 Quiachon et al. May 1997 A
5628788 Pinchuk May 1997 A
5632771 Boatman et al. May 1997 A
5632772 Alcime et al. May 1997 A
5636641 Fariabi Jun 1997 A
5637113 Tartaglia et al. Jun 1997 A
5639278 Dereume et al. Jun 1997 A
5645559 Hachtman et al. Jul 1997 A
D381932 Walshe et al. Aug 1997 S
5667522 Flomenblit et al. Sep 1997 A
5674276 Andersen et al. Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5690120 Jacobsen Nov 1997 A
5690644 Yurek et al. Nov 1997 A
5695499 Helgerson et al. Dec 1997 A
5700269 Pinchuk et al. Dec 1997 A
5702418 Ravenscroft Dec 1997 A
5709702 Cogita Jan 1998 A
5709703 Lukic et al. Jan 1998 A
5718159 Thompson Feb 1998 A
5725570 Heath Mar 1998 A
5733327 Igaki et al. Mar 1998 A
5735859 Fischell et al. Apr 1998 A
5741325 Chaikof et al. Apr 1998 A
5741333 Frid Apr 1998 A
5746765 Kleshinski et al. May 1998 A
5749883 Halpern May 1998 A
5749920 Quiachon et al. May 1998 A
5769884 Solovay Jun 1998 A
5769885 Quiachon et al. Jun 1998 A
5776099 Tremulis Jul 1998 A
5776142 Gunderson Jul 1998 A
5782909 Quiachon et al. Jul 1998 A
5797952 Klein Aug 1998 A
5800518 Piplani et al. Sep 1998 A
5810837 Hofmann et al. Sep 1998 A
5817102 Johnson et al. Oct 1998 A
5817105 Van Der Brug Oct 1998 A
5824039 Piplani et al. Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5824042 Lombardi et al. Oct 1998 A
5824044 Quiachon et al. Oct 1998 A
5824058 Ravenscroft et al. Oct 1998 A
5830229 Konya et al. Nov 1998 A
5833632 Jacobsen et al. Nov 1998 A
5836868 Ressemann et al. Nov 1998 A
5843168 Dang Dec 1998 A
5868754 Levine et al. Feb 1999 A
5876419 Carpenter et al. Mar 1999 A
5876445 Andersen Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5902266 Leone et al. May 1999 A
5902317 Kleshinski et al. May 1999 A
5906640 Penn et al. May 1999 A
5911717 Jacobsen et al. Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5919204 Lukic et al. Jul 1999 A
5928260 Chin et al. Jul 1999 A
5944728 Bates Aug 1999 A
5951599 McCrory Sep 1999 A
5957973 Quiachon et al. Sep 1999 A
5957974 Thompson et al. Sep 1999 A
5964797 Ho Oct 1999 A
5980530 Willard Nov 1999 A
5980533 Holman Nov 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
6012277 Prins et al. Jan 2000 A
6014919 Jacobsen et al. Jan 2000 A
6015432 Rakos et al. Jan 2000 A
6017319 Jacobsen et al. Jan 2000 A
6019778 Wilson et al. Feb 2000 A
6019786 Thompson Feb 2000 A
6022369 Jacobsen et al. Feb 2000 A
6024754 Engelson Feb 2000 A
6024763 Lenker et al. Feb 2000 A
6027516 Kolobow et al. Feb 2000 A
6033436 Steinke et al. Mar 2000 A
6039721 Johnson Mar 2000 A
6039758 Quiachon et al. Mar 2000 A
6042589 Marianne Mar 2000 A
6051021 Frid Apr 2000 A
6056993 Leidner et al. May 2000 A
6063111 Hieshima et al. May 2000 A
6074407 Levine et al. Jun 2000 A
6077295 Limon et al. Jun 2000 A
6080191 Summers Jun 2000 A
6083257 Taylor et al. Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096052 Callister et al. Aug 2000 A
6102942 Ahari Aug 2000 A
6123712 Di Caprio et al. Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6132459 Piplani et al. Oct 2000 A
6139543 Esch et al. Oct 2000 A
6146415 Fitz Nov 2000 A
6149680 Shelso et al. Nov 2000 A
6159228 Frid et al. Dec 2000 A
6161399 Jayaraman Dec 2000 A
6165194 Denardo Dec 2000 A
6165210 Lau et al. Dec 2000 A
6165213 Goicoechea et al. Dec 2000 A
6168592 Kupiecki et al. Jan 2001 B1
6174330 Stinson Jan 2001 B1
6183410 Jacobsen et al. Feb 2001 B1
6183508 Stinson et al. Feb 2001 B1
6187013 Stoltze et al. Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
6197046 Piplani et al. Mar 2001 B1
6203569 Wijay Mar 2001 B1
6206868 Parodi Mar 2001 B1
6210400 Hebert et al. Apr 2001 B1
6210434 Quiachon et al. Apr 2001 B1
6210435 Piplani et al. Apr 2001 B1
6214038 Piplani et al. Apr 2001 B1
6214042 Jacobsen et al. Apr 2001 B1
6221102 Baker et al. Apr 2001 B1
6224609 Ressemann et al. May 2001 B1
6224829 Piplani et al. May 2001 B1
6231598 Berry et al. May 2001 B1
6235050 Quiachon et al. May 2001 B1
6241759 Piplani et al. Jun 2001 B1
6245087 Addis Jun 2001 B1
6245103 Stinson Jun 2001 B1
6251132 Ravenscroft et al. Jun 2001 B1
6258115 Dubrul Jul 2001 B1
6260458 Jacobsen et al. Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6261316 Shaolian et al. Jul 2001 B1
6264671 Stack et al. Jul 2001 B1
6264689 Colgan et al. Jul 2001 B1
6270523 Herweck et al. Aug 2001 B1
6280465 Cryer Aug 2001 B1
6283991 Cox et al. Sep 2001 B1
6287331 Heath Sep 2001 B1
6287333 Appling et al. Sep 2001 B1
6290721 Heath Sep 2001 B1
6299636 Schmitt et al. Oct 2001 B1
6302810 Yokota Oct 2001 B2
6302893 Limon et al. Oct 2001 B1
6309353 Cheng et al. Oct 2001 B1
6322576 Wallace et al. Nov 2001 B1
6322586 Monroe et al. Nov 2001 B1
6322587 Quiachon et al. Nov 2001 B1
6325826 Vardi et al. Dec 2001 B1
6334871 Dor et al. Jan 2002 B1
6336938 Kavteladze et al. Jan 2002 B1
6340367 Stinson et al. Jan 2002 B1
6340368 Verbeck Jan 2002 B1
6342068 Thompson Jan 2002 B1
6344041 Kupiecki et al. Feb 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350199 Williams et al. Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6355051 Sisskind et al. Mar 2002 B1
6355061 Quiachon Mar 2002 B1
6364895 Greenhalgh Apr 2002 B1
6368339 Amplatz Apr 2002 B1
6368344 Fitz Apr 2002 B1
6368557 Piplani et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6375676 Cox Apr 2002 B1
6379618 Piplani et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6389946 Frid May 2002 B1
6395017 Dwyer et al. May 2002 B1
6395021 Hart et al. May 2002 B1
6395022 Piplani et al. May 2002 B1
6398802 Yee Jun 2002 B1
6409683 Fonseca et al. Jun 2002 B1
6413235 Parodi Jul 2002 B1
6416519 VanDusseldorp Jul 2002 B1
6416536 Yee Jul 2002 B1
6419693 Fariabi Jul 2002 B1
6428489 Jacobsen et al. Aug 2002 B1
6440088 Jacobsen et al. Aug 2002 B1
6443971 Boylan et al. Sep 2002 B1
6443979 Stalker Sep 2002 B1
6454999 Farhangnia et al. Sep 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6477768 Wildner Nov 2002 B1
6478778 Jacobsen et al. Nov 2002 B1
6482221 Hebert et al. Nov 2002 B1
6488705 Schmitt et al. Dec 2002 B2
6491648 Cornish et al. Dec 2002 B1
6494895 Addis Dec 2002 B2
6497711 Plaia et al. Dec 2002 B1
6503450 Afzal Jan 2003 B1
6514261 Randall et al. Feb 2003 B1
6514285 Pinchasik Feb 2003 B1
6524299 Tran et al. Feb 2003 B1
6527763 Esch et al. Mar 2003 B2
6533811 Ryan et al. Mar 2003 B1
6540778 Quiachon et al. Apr 2003 B1
6547779 Levine Apr 2003 B2
6551352 Clerc et al. Apr 2003 B2
6572646 Boylan et al. Jun 2003 B1
6576006 Limon et al. Jun 2003 B2
6582460 Cryer Jun 2003 B1
6582461 Burmeister et al. Jun 2003 B1
6589273 McDermott Jul 2003 B1
6592616 Stack et al. Jul 2003 B1
6595989 Schaer Jul 2003 B1
6602271 Adams et al. Aug 2003 B2
6602280 Chobotov Aug 2003 B2
6605110 Harrison Aug 2003 B2
6613075 Healy et al. Sep 2003 B1
6613078 Barone Sep 2003 B1
6622604 Chouinard et al. Sep 2003 B1
6623518 Thompson et al. Sep 2003 B2
6635068 Dubrul et al. Oct 2003 B1
6638243 Kupiecki Oct 2003 B2
6645240 Yee Nov 2003 B2
6646218 Campbell et al. Nov 2003 B1
6652508 Griffin et al. Nov 2003 B2
6652574 Jayaraman Nov 2003 B1
6656212 Ravenscroft et al. Dec 2003 B2
6656218 Denardo et al. Dec 2003 B1
6660024 Flaherty Dec 2003 B1
6660032 Klumb et al. Dec 2003 B2
6663666 Quiachon et al. Dec 2003 B1
6666881 Richter et al. Dec 2003 B1
6669719 Wallace Dec 2003 B2
6673089 Yassour et al. Jan 2004 B1
6673100 Diaz et al. Jan 2004 B2
6679893 Tran Jan 2004 B1
6682557 Quiachon et al. Jan 2004 B1
6685735 Ahari Feb 2004 B1
6689120 Gerdts Feb 2004 B1
6689162 Thompson Feb 2004 B1
6699274 Stinson Mar 2004 B2
6702843 Brown et al. Mar 2004 B1
6709454 Cox et al. Mar 2004 B1
6712834 Yassour et al. Mar 2004 B2
6726700 Levine Apr 2004 B1
6733519 Lashinski et al. May 2004 B2
6740105 Yodfat et al. May 2004 B2
6740112 Yodfat et al. May 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6755855 Yurek et al. Jun 2004 B2
6758885 Leffel et al. Jul 2004 B2
6767361 Quiachon et al. Jul 2004 B2
6773446 Dwyer et al. Aug 2004 B1
6793667 Hebert et al. Sep 2004 B2
6814746 Thompson et al. Nov 2004 B2
6814748 Baker et al. Nov 2004 B1
6818006 Douk et al. Nov 2004 B2
6833003 Jones et al. Dec 2004 B2
6849084 Rabkin et al. Feb 2005 B2
6858034 Hijlkema et al. Feb 2005 B1
6860893 Wallace et al. Mar 2005 B2
6860898 Stack et al. Mar 2005 B2
6860899 Rivelli, Jr. Mar 2005 B1
6860900 Clerc et al. Mar 2005 B2
6860901 Baker et al. Mar 2005 B1
6866677 Douk et al. Mar 2005 B2
6866679 Kusleika Mar 2005 B2
6866680 Yassour et al. Mar 2005 B2
6881221 Golds Apr 2005 B2
6887267 Dworschak et al. May 2005 B2
6890337 Feeser et al. May 2005 B2
6893451 Cano et al. May 2005 B2
6918921 Brady et al. Jul 2005 B2
6932837 Amplatz et al. Aug 2005 B2
6936055 Ken et al. Aug 2005 B1
6955685 Escamilla et al. Oct 2005 B2
6960227 Jones et al. Nov 2005 B2
6964670 Shah et al. Nov 2005 B1
6964672 Brady et al. Nov 2005 B2
6969396 Krolik et al. Nov 2005 B2
6976991 Hebert et al. Dec 2005 B2
6989024 Hebert et al. Jan 2006 B2
6994721 Israel Feb 2006 B2
7001422 Escamilla et al. Feb 2006 B2
7004962 Stinson Feb 2006 B2
7004964 Thompson et al. Feb 2006 B2
7011675 Hemerick et al. Mar 2006 B2
7037330 Rivelli, Jr. et al. May 2006 B1
7041129 Rourke et al. May 2006 B2
7066951 Chobotov Jun 2006 B2
7069835 Nishri et al. Jul 2006 B2
7074236 Rabkin et al. Jul 2006 B2
7093527 Rapaport et al. Aug 2006 B2
7101392 Heath Sep 2006 B2
7107105 Bjorklund et al. Sep 2006 B2
7118539 Vrba et al. Oct 2006 B2
7118594 Quiachon et al. Oct 2006 B2
7122050 Randall et al. Oct 2006 B2
7137990 Hebert et al. Nov 2006 B2
7166125 Baker et al. Jan 2007 B1
7169170 Widenhouse Jan 2007 B2
7169172 Levine et al. Jan 2007 B2
7172617 Colgan et al. Feb 2007 B2
7192434 Anderson et al. Mar 2007 B2
7195639 Quiachon et al. Mar 2007 B2
7195648 Jones et al. Mar 2007 B2
7201768 Diaz et al. Apr 2007 B2
7201769 Jones et al. Apr 2007 B2
7211109 Thompson May 2007 B2
7213495 McCullagh et al. May 2007 B2
7220271 Clubb et al. May 2007 B2
7235096 Van Tassel et al. Jun 2007 B1
7264632 Wright et al. Sep 2007 B2
7275471 Nishri et al. Oct 2007 B2
7279005 Stinson Oct 2007 B2
7279208 Goffena et al. Oct 2007 B1
7294137 Rivelli, Jr. et al. Nov 2007 B2
7294146 Chew et al. Nov 2007 B2
7300456 Andreas et al. Nov 2007 B2
7300460 Levine et al. Nov 2007 B2
7306624 Yodfat et al. Dec 2007 B2
7309351 Escamilla et al. Dec 2007 B2
7311031 McCullagh et al. Dec 2007 B2
7320702 Hammersmark et al. Jan 2008 B2
7323001 Clubb et al. Jan 2008 B2
7331973 Gesswein et al. Feb 2008 B2
7331976 McGuckin, Jr. et al. Feb 2008 B2
7331985 Thompson et al. Feb 2008 B2
7338518 Chobotov Mar 2008 B2
7438712 Chouinard Oct 2008 B2
7462192 Norton et al. Dec 2008 B2
7468070 Henry et al. Dec 2008 B2
7470282 Shelso Dec 2008 B2
7473271 Gunderson Jan 2009 B2
7491224 Cox et al. Feb 2009 B2
7520893 Rivelli, Jr. Apr 2009 B2
RE40816 Taylor et al. Jun 2009 E
7572288 Cox Aug 2009 B2
7572290 Yodfat et al. Aug 2009 B2
7588597 Frid Sep 2009 B2
7695507 Rivelli, Jr. et al. Apr 2010 B2
7763011 Ortiz et al. Jul 2010 B2
7771463 Ton et al. Aug 2010 B2
7854760 Molaei et al. Dec 2010 B2
7901447 Molaei et al. Mar 2011 B2
7942925 Yodfat et al. May 2011 B2
8007529 Yan Aug 2011 B2
8092486 Berrada et al. Jan 2012 B2
8092508 Leynov et al. Jan 2012 B2
8192484 Frid Jun 2012 B2
8382825 Garcia et al. Feb 2013 B2
8394119 Zaver et al. Mar 2013 B2
8398701 Berez et al. Mar 2013 B2
8617234 Garcia et al. Dec 2013 B2
8623067 Berez et al. Jan 2014 B2
8628564 Berez et al. Jan 2014 B2
8764817 Sheldon Jul 2014 B2
8801772 Shobayashi et al. Aug 2014 B2
8979918 Murayama Mar 2015 B2
9050205 Berez et al. Jun 2015 B2
9114001 Kusleika et al. Aug 2015 B2
9125659 Berez et al. Sep 2015 B2
20010027338 Greenberg Oct 2001 A1
20010044651 Steinke et al. Nov 2001 A1
20010049547 Moore Dec 2001 A1
20010056299 Thompson Dec 2001 A1
20020004667 Adams et al. Jan 2002 A1
20020007194 Plowiecki Jan 2002 A1
20020029061 Amplatz et al. Mar 2002 A1
20020035396 Heath Mar 2002 A1
20020062091 Jacobsen et al. May 2002 A1
20020078808 Jacobsen et al. Jun 2002 A1
20020082558 Samson et al. Jun 2002 A1
20020087119 Parodi Jul 2002 A1
20020111633 Stoltze et al. Aug 2002 A1
20020111648 Kusleika et al. Aug 2002 A1
20020120323 Thompson et al. Aug 2002 A1
20020138133 Lenz et al. Sep 2002 A1
20020143361 Douk et al. Oct 2002 A1
20020143384 Ozasa Oct 2002 A1
20020169473 Sepetka et al. Nov 2002 A1
20020169474 Kusleika et al. Nov 2002 A1
20020173839 Leopold et al. Nov 2002 A1
20020188314 Anderson et al. Dec 2002 A1
20020193864 Khosravi et al. Dec 2002 A1
20030009215 Mayer Jan 2003 A1
20030023299 Amplatz et al. Jan 2003 A1
20030069522 Jacobsen et al. Apr 2003 A1
20030100945 Yodfat et al. May 2003 A1
20030130684 Brady et al. Jul 2003 A1
20030135258 Andreas et al. Jul 2003 A1
20030163155 Haverkost et al. Aug 2003 A1
20030163156 Hebert et al. Aug 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030212429 Keegan et al. Nov 2003 A1
20030212430 Bose et al. Nov 2003 A1
20040024416 Yodfat et al. Feb 2004 A1
20040030265 Murayama et al. Feb 2004 A1
20040044395 Nelson Mar 2004 A1
20040073300 Chouinard et al. Apr 2004 A1
20040088037 Nachreiner et al. May 2004 A1
20040093010 Gesswein et al. May 2004 A1
20040098099 McCullagh et al. May 2004 A1
20040133223 Weber Jul 2004 A1
20040153117 Clubb et al. Aug 2004 A1
20040162606 Thompson Aug 2004 A1
20040172055 Huter et al. Sep 2004 A1
20040186368 Ramzipoor et al. Sep 2004 A1
20040193178 Nikolchev Sep 2004 A1
20040193179 Nikolchev Sep 2004 A1
20040193208 Talpade et al. Sep 2004 A1
20040199243 Yodfat Oct 2004 A1
20040210235 Deshmukh et al. Oct 2004 A1
20040215332 Frid Oct 2004 A1
20040220585 Nikolchev Nov 2004 A1
20040220608 D'Aquanni et al. Nov 2004 A1
20040220663 Rivelli Nov 2004 A1
20040254628 Nazzaro et al. Dec 2004 A1
20040260331 D'Aquanni et al. Dec 2004 A1
20050004595 Boyle et al. Jan 2005 A1
20050021075 Bonnette et al. Jan 2005 A1
20050033407 Weber et al. Feb 2005 A1
20050038447 Huffmaster Feb 2005 A1
20050051243 Forbes Jones et al. Mar 2005 A1
20050055047 Greenhalgh Mar 2005 A1
20050059889 Mayer Mar 2005 A1
20050060017 Fischell et al. Mar 2005 A1
20050090888 Hines et al. Apr 2005 A1
20050101989 Cully et al. May 2005 A1
20050137680 Ortiz et al. Jun 2005 A1
20050149111 Kanazawa et al. Jul 2005 A1
20050165441 McGuckin et al. Jul 2005 A1
20050177186 Cully et al. Aug 2005 A1
20050192620 Cully et al. Sep 2005 A1
20050197689 Molaei Sep 2005 A1
20050209672 George et al. Sep 2005 A1
20050209678 Henkes et al. Sep 2005 A1
20050246010 Alexander et al. Nov 2005 A1
20050267568 Berez et al. Dec 2005 A1
20050283220 Gobran et al. Dec 2005 A1
20050288764 Snow Dec 2005 A1
20050288766 Plain et al. Dec 2005 A1
20060020324 Schmid et al. Jan 2006 A1
20060036309 Hebert et al. Feb 2006 A1
20060089703 Escamilla et al. Apr 2006 A1
20060095213 Escamilla et al. May 2006 A1
20060111771 Ton et al. May 2006 A1
20060116713 Sepetka et al. Jun 2006 A1
20060116750 Hebert et al. Jun 2006 A1
20060184238 Kaufmann et al. Aug 2006 A1
20060195118 Richardson Aug 2006 A1
20060206148 Khairkhahan et al. Sep 2006 A1
20060206200 Garcia et al. Sep 2006 A1
20060206201 Garcia et al. Sep 2006 A1
20060212127 Karabey et al. Sep 2006 A1
20060271149 Berez et al. Nov 2006 A1
20060271153 Garcia et al. Nov 2006 A1
20060276910 Weber Dec 2006 A1
20070021816 Rudin Jan 2007 A1
20070043419 Nikolchev et al. Feb 2007 A1
20070055365 Greenberg et al. Mar 2007 A1
20070060994 Gobran et al. Mar 2007 A1
20070073379 Chang Mar 2007 A1
20070077347 Richter Apr 2007 A1
20070100321 Rudakov et al. May 2007 A1
20070100414 Licata May 2007 A1
20070100430 Rudakov et al. May 2007 A1
20070112415 Bartlett May 2007 A1
20070119295 McCullagh May 2007 A1
20070123969 Gianotti May 2007 A1
20070162104 Frid Jul 2007 A1
20070167980 Figulla et al. Jul 2007 A1
20070198076 Hebert et al. Aug 2007 A1
20070203559 Freudenthal et al. Aug 2007 A1
20070203563 Hebert et al. Aug 2007 A1
20070208367 Fiorella et al. Sep 2007 A1
20070208373 Zaver et al. Sep 2007 A1
20070208376 Meng Sep 2007 A1
20070208415 Grotheim et al. Sep 2007 A1
20070219619 Dieck et al. Sep 2007 A1
20070225760 Moszner et al. Sep 2007 A1
20070233175 Zaver et al. Oct 2007 A1
20070239261 Bose et al. Oct 2007 A1
20070255386 Tenne Nov 2007 A1
20070255388 Rudakov et al. Nov 2007 A1
20070280850 Carlson Dec 2007 A1
20070299500 Hebert et al. Dec 2007 A1
20070299501 Hebert et al. Dec 2007 A1
20070299502 Hebert et al. Dec 2007 A1
20080015673 Chuter Jan 2008 A1
20080033341 Grad Feb 2008 A1
20080033526 Atladottir et al. Feb 2008 A1
20080039930 Jones et al. Feb 2008 A1
20080039933 Yodfat Feb 2008 A1
20080071351 Flanagan et al. Mar 2008 A1
20080082154 Tseng et al. Apr 2008 A1
20080114391 Dieck et al. May 2008 A1
20080119943 Armstrong et al. May 2008 A1
20080125855 Henkes et al. May 2008 A1
20080208320 Tan-Malecki et al. Aug 2008 A1
20080221666 Licata et al. Sep 2008 A1
20080221670 Clerc et al. Sep 2008 A1
20080221671 Chouinard et al. Sep 2008 A1
20080255654 Hebert et al. Oct 2008 A1
20080255655 Kusleika et al. Oct 2008 A1
20080262590 Murray Oct 2008 A1
20080269774 Garcia et al. Oct 2008 A1
20080275497 Palmer et al. Nov 2008 A1
20080275498 Palmer et al. Nov 2008 A1
20080294104 Mawad Nov 2008 A1
20080300667 Hebert et al. Dec 2008 A1
20080300668 Bonsignore Dec 2008 A1
20080300673 Clerc et al. Dec 2008 A1
20090024202 Dave et al. Jan 2009 A1
20090024205 Hebert et al. Jan 2009 A1
20090030496 Kaufmann et al. Jan 2009 A1
20090030497 Metcalf et al. Jan 2009 A1
20090054981 Frid et al. Feb 2009 A1
20090099643 Hyodoh et al. Apr 2009 A1
20090105802 Henry et al. Apr 2009 A1
20090105803 Shelso Apr 2009 A1
20090125093 Hansen May 2009 A1
20090192536 Berez et al. Jul 2009 A1
20090192587 Frid Jul 2009 A1
20090198318 Berez et al. Aug 2009 A1
20090216307 Kaufmann et al. Aug 2009 A1
20090222035 Schneiderman Sep 2009 A1
20090270974 Berez et al. Oct 2009 A1
20090287241 Berez et al. Nov 2009 A1
20090287288 Berez et al. Nov 2009 A1
20090288000 McPherson Nov 2009 A1
20090292348 Berez et al. Nov 2009 A1
20090318947 Garcia et al. Dec 2009 A1
20090319017 Berez et al. Dec 2009 A1
20100010624 Berez et al. Jan 2010 A1
20100042200 Richter et al. Feb 2010 A1
20100061604 Nahm et al. Mar 2010 A1
20100063531 Rudakov et al. Mar 2010 A1
20100070024 Venturelli et al. Mar 2010 A1
20100076317 Babic et al. Mar 2010 A1
20100152834 Hannes et al. Jun 2010 A1
20100161025 Kuppurathanam et al. Jun 2010 A1
20100174269 Tompkins et al. Jul 2010 A1
20100174309 Fulkerson et al. Jul 2010 A1
20100179583 Carpenter et al. Jul 2010 A1
20100179647 Carpenter et al. Jul 2010 A1
20100198334 Yodfat et al. Aug 2010 A1
20100204779 Schuessler et al. Aug 2010 A1
20100211154 Murayama Aug 2010 A1
20100222864 Rivelli, Jr. et al. Sep 2010 A1
20100241214 Holzer et al. Sep 2010 A1
20100256732 Shin et al. Oct 2010 A1
20100256733 Schuessler Oct 2010 A1
20100280587 Ortiz et al. Nov 2010 A1
20100318174 Shaolian et al. Dec 2010 A1
20100318178 Rapaport et al. Dec 2010 A1
20110016427 Douen Jan 2011 A1
20110040372 Hansen et al. Feb 2011 A1
20110046718 Cattaneo Feb 2011 A1
20110046720 Shalev et al. Feb 2011 A1
20110054589 Bashiri et al. Mar 2011 A1
20110166592 Garcia et al. Jul 2011 A1
20110166637 Irwin et al. Jul 2011 A1
20110166639 Pulnev et al. Jul 2011 A1
20110179389 Douen Jul 2011 A1
20110184451 Sahl Jul 2011 A1
20110190862 Bashiri et al. Aug 2011 A1
20110245862 Dieck et al. Oct 2011 A1
20110270178 Fiorella et al. Nov 2011 A1
20120035643 Khairkhahan et al. Feb 2012 A1
20120041459 Fiorella et al. Feb 2012 A1
20120158124 Zaver et al. Jun 2012 A1
20120253454 Costello Oct 2012 A1
20120290067 Cam Nov 2012 A1
20120316638 Grad et al. Dec 2012 A1
20120323309 Cattaneo Dec 2012 A1
20130116773 Roeder et al. May 2013 A1
20130123901 Connor et al. May 2013 A1
20130138202 Paul et al. May 2013 A1
20130172975 Berez et al. Jul 2013 A1
20130190856 von Oepen et al. Jul 2013 A1
20130204347 Armstrong et al. Aug 2013 A1
20130211489 Makower et al. Aug 2013 A1
20130211497 Charlebois et al. Aug 2013 A1
20130274849 Zaver et al. Oct 2013 A1
20140018843 Berez et al. Jan 2014 A1
20140074149 Garcia et al. Mar 2014 A1
20140121744 Kusleika May 2014 A1
20140121746 Kusleika et al. May 2014 A1
20140128957 Losordo et al. May 2014 A1
20140222130 Kusleika Aug 2014 A1
20140316454 Zaver et al. Oct 2014 A1
20140336741 Connor et al. Nov 2014 A1
20150305748 Berez et al. Oct 2015 A1
20150313736 Berez et al. Nov 2015 A1
20150359646 Kusleika et al. Dec 2015 A1
20160022451 Kusleika Jan 2016 A1
Foreign Referenced Citations (52)
Number Date Country
101472537 Jul 2009 CN
855170 Jul 1998 EP
1683541 Jul 2006 EP
1942972 Jul 2008 EP
1872742 May 2009 EP
2 078 512 Jul 2009 EP
2556210 Apr 1988 FR
10-328216 Dec 1998 JP
11-506686 Jun 1999 JP
11-299901 Nov 1999 JP
2001-509412 Jul 2001 JP
2002-253682 Sep 2002 JP
2003-520103 Jul 2003 JP
2004-049585 Feb 2004 JP
2005-074230 Mar 2005 JP
2006-506201 Feb 2006 JP
2008-502378 Jan 2008 JP
2008-541832 Nov 2008 JP
WO-8800813 Feb 1988 WO
WO-9509586 Apr 1995 WO
WO-9532757 Dec 1995 WO
WO-9804211 Feb 1998 WO
WO-9847447 Oct 1998 WO
WO-9902092 Jan 1999 WO
WO-9905977 Feb 1999 WO
WO-9949812 Dec 1999 WO
WO-0105331 Jan 2001 WO
WO-0152771 Jul 2001 WO
WO-0205729 Jan 2002 WO
WO-0247579 Jun 2002 WO
WO-02054988 Jan 2003 WO
WO-03007840 Jan 2003 WO
WO-03043527 May 2003 WO
WO-03049600 Jun 2003 WO
WO-03057079 Jul 2003 WO
WO-03073963 Sep 2003 WO
WO-2004087006 Nov 2004 WO
WO-2005021061 Mar 2005 WO
WO-2005023149 Dec 2005 WO
WO-2006034140 Mar 2006 WO
WO-2006073745 Jul 2006 WO
WO-2006127005 Nov 2006 WO
WO-2007122396 Nov 2007 WO
WO-2008005898 Jan 2008 WO
WO-2007139689 Sep 2008 WO
WO-2007139699 Sep 2008 WO
WO-2008156683 Dec 2008 WO
WO-2005115118 Jul 2009 WO
WO-2009105710 Aug 2009 WO
WO-2010127838 Nov 2010 WO
WO-2011023105 Mar 2011 WO
WO-2011134663 Nov 2011 WO
Non-Patent Literature Citations (15)
Entry
Benndorf, et al. Treatment of a Ruptured Dissecting Vertebral Artery Aneurysm with Double Stent Placement: Case Report AJNR Am J Neuroradiol, Nov.-Dec. 2001, vol. 22, pp. 1844-1848.
Brilstra, et al., Treatment of Intracranial Aneurysms by Embolization with Coils: A Systematic Review, Stroke, Journal of the American Heart Association, 1999, vol. 30, pp. 470-476.
Ferguson, Gary, Physical Factors in the Initiation, Growth and Rupture of Human Intracranial Saccular Aneurysms, J. Neurosurg, Dec. 1972, vol. 37, pp. 666-667.
Geremia, et al., Embolization of Experimentally Created Aneurysms with Intravascular Stent Devices, ANJR American Journal of Neuroradiology, Aug. 1994, vol. 15, pp. 1223-1231.
Geremia, et al., Occlusion of Experimentally Created Fusiform Aneurysms with Porous Metallic Stents, ANJR Am J Neuroradiol, Apr. 2000, Issue 21, pp. 739-745.
Lanzino, et al., Efficacy and Current Limitations of Intravascular Stents for Intracranial Internal Carotid, Vertebral, and Basilar Artery Aneurysms, Journal of Neurosurgery, Oct. 1999, vol. 91, Issue 4, pp. 538-546.
Lieber, et al., Alteration of Hemodynamits in Aneurysm Models by Stenting: Influence of Stent Porosity, Ann of Biomedical Eng., 1997, vol. 25, pp. 460-469, Buffalo, NY.
Lieber, et al., The Physics of Endoluminal Stenting in the Treatment of Cerebrovascular Aneurysms, Neurological Research, 2002, Vcol 24, Issue Supplement 1, pp. S32-S42.
Moss, et al., Vascular Occlusion with a Balloon-Expandable Stent Occluder, Radiology, May 1994, vol. 191, Issue 2, pp. 483-486.
Pereira, Edgard, History of Endovascular Aneurysm Occlusion, Management of Cerebral Aneurysms, 2004, pp. 11-26.
Qureshi, Adnan, Endovascular Treatment of Cerebrovascular Diseases and Intracranial Neoplasms, The Lancelet, Mar. 2004, vol. 363, pp. 804-813.
Steiger, Pathophysiology of Development and Rupture of Cerebral Aneurysms, Acta Nurochirurgica, Mar. 1990, vol. Supplementum 48, Pages in 62 pages.
Tenaglia, et al., Ultrasound Guide Wire-Directed Stent Deployment, Duke University Medical Center, Department of Medicine, 1993 USA.
Yu, et al., A Steady Flow Analysis on the Stented and Non-Stented Sidewall Aneurysm Models, Medical Engineering and Physics, Apr. 1999, Issue 21, pp. 133-141.
U.S. Appl. No. 15/082,404, filed Mar. 28, 2016.
Related Publications (1)
Number Date Country
20160310300 A1 Oct 2016 US
Provisional Applications (1)
Number Date Country
60775818 Feb 2006 US
Continuations (3)
Number Date Country
Parent 13792344 Mar 2013 US
Child 15137364 US
Parent 13407044 Feb 2012 US
Child 13792344 US
Parent 11708651 Feb 2007 US
Child 13407044 US